Product Information
MEMANTINE HCL ER 14 MG CAPSULE is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.3391 per EA under NDC 69680016230. Its NADAC has been published 64 times since Jun 4, 2025.
FDA first approved this application on Oct 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
14 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680016230
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213985FDA Approved
10/11/2022
TE Code
AB
On Market Since
12/15/2023
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL ER 14 MG CAPSULE has been published 64 times since Jun 4, 2025, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3391 per EA |
|---|---|
| All-time high | $0.4396 (Jun 11, 2025) |
| All-time low | $0.2748 (Feb 18, 2026) |
| 52-week high | $0.3926 |
| 52-week low | $0.2748 |
| Median price | $0.3332 |
| Average price | $0.3439 |
| Largest weekly change | -13.8% (Dec 17, 2025) |
| Weeks tracked | 64 |
| Tracking since | Jun 4, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEMANTINE HCL ER 14 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL ER 14 MG CAPSULE, manufactured by Vitruvias Therapeutics Inc., is $0.3391 per EA (NDC 69680016230), effective Aug 19, 2026.
How has the price of MEMANTINE HCL ER 14 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL ER 14 MG CAPSULE has declined 22.9%. It has been tracked across 64 weekly CMS publications since Jun 4, 2025.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL ER 14 MG CAPSULE?
Since Jun 4, 2025, the NADAC for MEMANTINE HCL ER 14 MG CAPSULE has ranged from a low of $0.2748 (Feb 18, 2026) to a high of $0.4396 (Jun 11, 2025), with a median of $0.3332 per EA.
Are there cheaper alternatives to MEMANTINE HCL ER 14 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEMANTINE HCL ER 14 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MEMANTINE HCL ER 14 MG CAPSULE?
MEMANTINE HCL ER 14 MG CAPSULE (NDC 69680016230) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.